Roberts Zachary bought ALLO
July 1, 2026 · Form 4 insider transaction
Roberts Zachary bought 134,530 shares of Allogene Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
134,530
Price
$0.00
Total value
N/A
InsiderRoberts Zachary
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 6, 2026
Shares owned after134,530
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period measured from July 20, 2026, subject to continued service through the vesting date.